Products

Dartsita-D 5/10/50/100

BRAND NAME: Dartsita - D5/D10/D50/D100

PACKING:  1x10

INDICATED IN: In Type 2 Diabetes Mellitus

Composition

  • Dapagliflozin 5mg + Sitagliptin 50mg
  • Dapagliflozin 10mg + Sitagliptin 100mg

Mode of Action

Dartsita-D is a combination of two anti-diabetic drugs namely Dapagliflozin and Sitagliptin

Sitagliptin: Sitagliptin increases insulin production and decreases hepatic glucose overproduction. Sitagliptin prolongs the action of GLP-1 and GIP. By enhancing active incretin levels, sitagliptin increases insulin production and lowers glucagon secretion from alpha cells, which decreases hepatic glucose overproduction.

Dapagliflozin: By inhibiting SGLT2, dapagliflozin blocks reabsorption of filtered glucose in the kidney, increasing urinary glucose excretion and reducing blood glucose levels. Its mechanism of action is independent of pancreatic β cell function and modulation of insulin sensitivity.

Benefits

Dapagliflozin + Sitagliptin is used alone or together with other diabetes medicines to control blood sugar and avoid long-term complications. It also reduces the risk of heart attack, heart failure or other cardiovascular events.

Usage

warnings As directed by your doctor.


warnings Along with proper diet and exercise.


warnings Dartsita-D5 & Dartsita-D50 tablets should be taken with or without food.

Precautions

warnings Alcohol

Avoid drinking alcohol. It may cause hypoglycemia (low blood sugar level).


warnings Pregnancy

Make sure your doctor knows if you are pregnant or planning to become pregnant.


warnings Medicine

Do not take other medicines unless they have been discussed with your doctor.


warnings Liver & Kidney

Should be used with caution in patients with liver & kidney disease.